![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2020 17:40 | Well one good point is that if it appeared in the current sites that SNG001 was having detrimental effects, they wouldn’t be setting up new sites | ![]() peachie 74 | |
16/4/2020 17:35 | hxxps://www.thelance | ![]() talk2dubya | |
16/4/2020 17:12 | based on the fact they are still recruiting and time to analyse results, I would imagine Nobby's guesstimate of when results will be known is reasonably accurate. | ![]() potts650 | |
16/4/2020 17:09 | Good stuff. So there are at least 4 sites which are recruiting now Southampton, Leicester, Birmingham and Manchester. As I have said before it is vital to get all 7 sites up and running as quickly as possible so that the patients can be recruited rapidly. | ![]() nobbygnome | |
16/4/2020 17:03 | Good find Likya | ![]() 141jaffa | |
16/4/2020 16:58 | 1st patient | ![]() likya123 | |
16/4/2020 16:23 | Ascending rising channel lower target of 62.2p hit earlier and now rising into close. Tomorrow we rise towards 80p+ back into the continued ascending channel pattern, unless ofcourse we get a blockbuster RNS. | ![]() likya123 | |
16/4/2020 16:13 | BM - should I go about ramping SNG over on the NSCI board ? No I won’t, because I am not a complete bell. | ![]() talk2dubya | |
16/4/2020 16:09 | Call me a prophet. It appears the MM's are short of stock | ![]() vitec | |
16/4/2020 16:07 | Next movement will be up | ![]() vitec | |
16/4/2020 16:04 | NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, today announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq: PDSB) announced today an expanded infectious disease pandemic development program, including novel vaccines for COVID-19 and universal influenza, in addition to its previously announced tuberculosis development collaboration with Farmacore Biotechnology. PDS Biotech's products combine its novel Versamune(R) technology with custom-designed, disease-specific proteins to induce both neutralizing antibody and killer (CD8+) T-cell responses, which when co-induced are more powerful in fighting disease than either alone. This proven Versamune(R) mechanism, combined with a favorable safety profile, provides a strong rationale to expand the development of Versamune(R)-based products beyond its initial series of cancer immunotherapies to add potentially transformative vaccines to protect and fight against infectious agents, including COVID-19, influenza, and tuberculosis. | ![]() bmnsa | |
16/4/2020 15:59 | From lse board... Has anyone seen this? I thought it was interesting in explaining that despite a "combination of IFNß with lopinavir/ritonavir against MERS-CoV improved pulmonary function but did not significantly educe virus replication or lung pathology severity", that IFNß1 appears to be most relevant interferon to treat coronavirus infections. | ![]() likya123 | |
16/4/2020 15:48 | So how quickly do we think our new ‘IIs’ will be able to dump their stock? I do think we are seeing some PIs rainbow chasing here as well. | ![]() talk2dubya | |
16/4/2020 15:48 | NAH - social isolation precludes | ![]() toffeeman | |
16/4/2020 15:45 | I think a few of you have been around TPI's house and drinking with him | ![]() vitec | |
16/4/2020 15:44 | 4-30 close | ![]() tialouise | |
16/4/2020 15:40 | 80p close imo. | ![]() dealer55 | |
16/4/2020 15:33 | Don't you mean 60? ): | ![]() toffeeman | |
16/4/2020 15:28 | Looks like 70p close | ![]() peachie 74 | |
16/4/2020 15:09 | Plus they have a 17% share of a promising fibrosis drug which has completed phase I. SNG is far from a one trick pony.... | ![]() nobbygnome | |
16/4/2020 15:00 | Looking like 60p close | ![]() jonnynixon | |
16/4/2020 14:53 | Remember SNG is not purely Covid-19 play. They are also trying to treat COPD & severe asthma, which is why I invested in them. £50m-£60m mcap for drug companies in trials is not uncommon. If the trials are successful then the mcap would be many times. If they fail the share price would crash but I doubt it would be nil, given they are likely to continue to find treatments for COPD. | ![]() sikhthetech | |
16/4/2020 14:50 | NSCI screaming news I hope someone took note of my post last evening ? fanramptastic mate - 15 Apr 2020 - 18:34:35 - 3818 of 3924 Synairgen - a potential cure for Covid 19? - SNG NSCI Ichimoku charting With todays closing share price well above the turbulent KUMO cloud we have achieved breakout and as such should now post a STRONG BULL signal. Hopefully more of the same tomorrow fanny | ![]() fanramptastic mate |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions